An Alternative Perspective towards Reducing the Risk of Engineered Nanomaterials to Human Health.
3Rs
alternatives
in vitro systems
nanosafety
reduction
replacement
Journal
Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
27
03
2020
revised:
09
07
2020
pubmed:
6
8
2020
medline:
18
5
2021
entrez:
6
8
2020
Statut:
ppublish
Résumé
To elucidate the impact of human exposure to engineered nanomaterials, advanced in vitro models are a valid non-animal alternative. Despite significant gains over the last decade, implementation of these approaches remains limited. This work discusses the current state-of-the-art and how future developments can lead to advanced in vitro models better supporting nano-hazard assessment.
Identifiants
pubmed: 32755066
doi: 10.1002/smll.202002002
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2002002Informations de copyright
© 2020 The Authors. Published by Wiley-VCH GmbH.
Références
European Union, Definition of a Nanomaterial (2011/696/EU), https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32011H0696 (accessed: March 2020).
A. D. Maynard, Nature 2011, 475, 31.
International Organization for Standardization, ISO/TS 229:2005, https://www.iso.org/committee/381983.html (accessed: March 2020).
K. Gajanan, S. N. Tijare, Mater. Today: Proc. 2018, 5, 1093.
E. Inshakova, O. Inshakov, MATEC Web Conf. 2017, 129, 02013.
B. Dreno, A. Alexis, B. Chuberre, M. Marinovich, J. Eur. Acad. Dermatol. Venereol. 2019, 33, 34.
Titanium Dioxide Manufacturers Association (TDMA), https://tdma.info/what-you-should-know-about-eu-titanium-dioxide-regulations/ (accessed: March 2020).
C. O. Hendren, X. Mesnard, J. Droge, M. R. Wiesner, Environ. Sci. Technol. 2011, 45, 2562.
S. Jafari, in Carbon Nanotube-Reinforced Polymers: From Nanoscale to Macroscale, Elsevier, New York 2018.
K. Donaldson, C. A. Poland, F. A. Murphy, M. MacFarlane, T. Chernova, A. Schinwald, Adv. Drug Delivery Rev. 2013, 65, 2078.
M. J. Pitkethly, Mater. Today 2004, 7, 20.
M. E. Vance, T. Kuiken, E. P. Vejerano, S. P. McGinnis, M. F. Hochella, D. Rejeski, M. S. Hull, Beilstein J. Nanotechnol. 2015, 6, 1769.
A. Pietroiusti, H. Stockmann-Juvala, F. Lucaroni, K. Savolainen, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2018, 10, e1513.
P. J. A. Borm, D. Robbins, S. Haubold, T. Kuhlbusch, H. Fissan, K. Donaldson, R. Schins, V. Stone, W. Kreyling, J. Lademann, J. Krutmann, D. Warheit, E. Oberdorster, Part. Fibre Toxicol. 2006, 3, 11.
G. Oberdorster, E. Oberdorster, J. Oberdorster, Environ. Health Perspect. 2005, 113, 823.
K. Savolainen, U. Backman, D. Brouwer, B. Fadeel, T. Fernandes, T. Kuhlbusch, R. Landsiedel, I. Lynch, L. Pylkkanen, Nanosafety in Europe 2015-2025: Towards Safe and Sustainable Nanomaterials and Nanotechnology Innovations, www.ttl.fi/en/publications/electronic_publications/pages/default.aspx (accessed: March 2020).
J. Ferin, G. Oberdorster, D. P. Penney, Am. J. Respir. Cell Mol. Biol. 1992, 6, 535.
K. Donaldson, V. Stone, C. L. Tran, W. Kreyling, P. J. Borm, Occup. Environ. Med. 2004, 61, 727.
H. Bouwmeester, I. Lynch, H. J. Marvin, K. A. Dawson, M. Berges, D. Braguer, H. J. Byrne, A. Casey, G. Chambers, M. J. D. Clift, G. Elia, T. F. Fernandes, L. B. Fjellsbo, P. Hatto, L. Juillerat, C. Klein, W. G. Kreyling, C. Nickel, M. Riediker, V. Stone, Nanotoxicology 2011, 5, 1.
V. Stone, M. R. Miller, M. J. D. Clift, A. Elder, N. L. Mills, P. Moller, R. P. F. Schins, U. Vogel, W. G. Kreyling, K. A. Jensen, T. A. J. Kuhlbusch, P. E. Schwarze, P. Hoet, A. Pietroiusti, A. De Vizcaya-Ruiz, A. Baeza-Squiban, J. P. Teixeira, C. L. Tran, F. R. Cassee, Environ. Health Perspect. 2017, 125, 106002.
A. Sukhanova, S. Bozrova, P. Sokolov, M. Berestovoy, A. Karaulov, I. Nabiev, Nanoscale Res. Lett. 2018, 13, 44.
V. De Matteis, R. Rinaldi, in Cellular and Molecular Toxicology of Nanoparticles, Advances in Experimental Medicine and Biology, Vol. 1048, Springer, Cham 2018.
N. Burden, K. Aschberger, Q. Chaudhry, M. J. D. Clift, S. H. Doak, P. Fowler, H. Johnston, R. Landsiedel, J. Rowland, V. Stone, Nano Today 2017, 12, 10.
European Union, Cosmetics Ban on Animal Experimentation (EC No 1223/2009), https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02009R1223-20190813 (accessed: March 2020).
S. Raj, S. Jose, U. S. Sumod, M. Sabitha, J. Pharm. BioAllied Sci. 2012, 4, 186.
T. Hartung, G. Daston, Toxicol. Sci. 2009, 111, 233.
N. Burden, K. Aschberger, Q. Chaudhry, M. J. D. Clift, P. Fowler, H. Johnston, R. Landsiedel, J. Rowland, V. Stone, S. H. Doak, Regul. Toxicol. Pharmacol. 2017, 91, 257.
M. R. Fielden, K. L. Kolaja, Expert Opin. Drug Saf. 2008, 7, 107.
E. E. McConnell, Ann. Occup. Hyg. 1995, 39, 727.
N. Vargesson, Birth Defects Res., Part C 2015, 105, 140.
K. C. Brannen, R. E. Chapin, A. C. Jacobs, M. L. Green, ILAR J. 2016, 57, 144.
S. F. Ryan, S. A. Hashim, G. Cernansky, C. R. Barrett, A. L. L. Bell, D. F. Liau, J. Lipid Res. 1980, 21, 1004.
W. Hofmann, L. Koblinger, T. B. Martonen, Health Phys. 1989, 57, 41.
B. Asgharian, O. Price, G. McClellan, R. Corley, D. R. Einstein, R. E. Jacob, J. Harkema, S. A. Carey, E. Schelegle, D. Hyde, J. S. Kimbell, F. J. Miller, Inhalation Toxicol. 2012, 24, 869.
J. Dong, J. Ma, L. Tian, K. Inthavong, J. Tu, Int. J. Environ. Res. Public Health 2019, 16, 2571.
J. Mestas, C. C. W. Hughes, J. Immunol. 2004, 172, 2731.
K. Fischer, Eur. J. Risk Regul. 2015, 6, 613.
M. A. Cabrera-Perez, M. B. Sanz, V. M. Sanjuan, M. Gonzalez-Alvarez, I. G. Alvarez, Concepts and Models for Drug Permeability Studies: Cell and Tissue Based In Vitro Culture Models, Elsevier, New York 2016.
S. J. Evans, M. J. D. Clift, N. Singh, J. de Oliveira Mallia, M. Burgum, J. W. Wills, T. S. Wilkinson, G. J. S. Jenkins, S. H. Doak, Mutagenesis 2017, 32, 233.
M. R. Fabbrizi, T. Duff, J. Oliver, C. Wilde, Eur. J. Nanomed. 2014, 6, 171.
R. Edmondson, J. J. Broglie, A. F. Adcock, L. Yang, Assay Drug Dev. Technol. 2014, 12, 207.
D. Schuerch, D. Vanhecke, M. J. D. Clift, D. Raemy, D. J. de Aberasturi, W. J. Parak, P. Gehr, A. Petri-Fink, B. Rotheen-Rutishauser, Langmuir 2014, 30, 4924.
K.-T. Rim, Toxicol. Environ. Health Sci. 2019, 11, 94.
C. T. Hanks, J. C. Wataha, Z. Sun, Dent. Mater. 1996, 12, 186.
F. J. O’Brien, Mater. Today 2011, 14, 88.
B. M. Rothen-Rutishauser, S. G. Kiama, P. Gehr, Am. J. Respir. Cell Mol. Biol. 2005, 32, 281.
Q. Xu, J. T. Norman, S. Shrivastav, J. Lucio-Cazana, J. B. Kopp, Am. J. Physiol.: Renal Physiol. 2007, 293, F631.
OECD Test No. 487: In Vitro Mammalian Cell Micronucleus Test, https://www.oecd.org/env/ehs/testing/test-no-487-in-vitro-mammalian-cell-micronucleus-test-9789264264861-en.htm (accessed: March 2020).
M. J. D. Clift, C. Endes, D. Vanhecke, P. Wick, P. Gehr, R. P. F. Schins, A. Petri-Fink, B. Rothen-Rutishauser, Toxicol. Sci. 2014, 137, 55.
M. A. Hoogenkamp, B. W. Brandt, J. J. de Soet, W. Crielaard, J. Microbiol. Methods 2020, 171, 105879.
T. L. Moore, D. Hauser, T. Gruber, B. Rothen-Rutishauser, M. Lattuada, A. Petri-Fink, R. Lyck, ACS Appl. Mater. Interfaces 2017, 9, 18501.
P. Dan, E. Velot, V. Decot, P. Menu, J. Cell Sci. 2015, 128, 2415.
B. Zhang, A. Korolj, B. F. L. Lai, M. Radisic, Nat. Rev. Mater. 2018, 3, 257.
G. Lacroix, W. Koch, D. Ritter, A. C. Gutleb, S. T. Larsen, T. Loret, F. Zanetti, S. Constant, S. Chortarea, B. Rothen-Rutishauser, P. S. Hiemstra, E. Frejafon, P. Hubert, L. Gribaldo, P. Kearns, J.-M. Aublant, S. Diabate, C. Weiss, A. de Groot, I. Kooter, Appl. In Vitro Toxicol. 2018, 4, 91.
J. W. Wills, N. Hondow, A. D. Thomas, K. E. Chapman, D. Fish, T. G. Maffeis, M. W. Penny, R. A. Brown, G. J. S. Jenkins, A. P. Brown, P. A. White, S. H. Doak, Part. Fibre Toxicol. 2015, 13, 50.
A. O. Stucki, J. D. Stucki, S. R. R. Hall, M. Felder, Y. Mermoud, R. A. Schmid, T. Geiser, O. T. Guenat, Lab Chip 2015, 15, 1302.
E. J. A. Veldhuizen, H. P. Haagsman, Biochim. Biophys. Acta, Biomembr. 2000, 1467, 255.
D. G. Harnden, The Cultured Cell and Inherited Metabolic Disease, Springer, New York 1977.
D. Brunner, J. Frank, H. Appl, H. Schoeffl, W. Pfaller, G. Gstraunthaler, ALTEX 2010, 27, 53.
B. N. Snyder-Talkington, C. Dong, X. Zhao, J. Dymacek, D. W. Porter, M. G. Wolfarth, V. Castronova, Y. Qian, N. L. Guo, Toxicology 2015, 328, 66.
H. J. Cho, J. E. Kim, D. D. Kim, I. S. Yoon, Drug Dev. Ind. Pharm. 2014, 40, 989.
Adverse Outcome Pathway WIKI, https://aopwiki.org/wiki/index.php/Aop:173 (accessed: March 2020).
S. Labib, A. Williams, C. L. Yauk, J. K. Niikota, H. Wallin, U. Vogel, S. Halappanavar, Part. Fibre Toxicol. 2015, 13, 15.
H. Barosova, A. G. Maione, D. Septiadi, M. Sharma, L. Haeni, S. Balog, O. O’Connell, G. R. Jackson, D. Brown, A. J. Clippinger, P. Hayden, A. Petri-Fink, V. Stone, B. Rothen-Rutishauser, ACS Nano 2020, 14, 3941.